Literature DB >> 30498412

Evaluation of the New Lateral Flow Card MDmulticard® Basic Extended Phenotype in Routine Clinical Practice.

Beate Mayer1, Julia Müller2, María-José Candela-García3, Annie-Claude Manteau4, Christof Weinstock2, Axel Pruß1.   

Abstract

BACKGROUND: Transfusion emergencies and critical situations require specifically designed devices to simplify and optimize the standard procedures. In addition, matching antigens over and above ABO-Rh-K would be beneficial.
METHODS: Routine blood samples were collected in four immunohematology centers and tested with the new MDmulticard Basic Extended Phenotype for the simultaneous detection of the Duffy, Kidd, and Ss antigens, according to the principle of the lateral flow. Results were compared with those obtained using routine serology methods. Discrepancies were analyzed by molecular techniques/genotyping.
RESULTS: 310 samples were tested (167 donors; 75 patients; 28 subjects with positive direct antiglobulin test (DAT); 15 newborns; 25 previously transfused patients). The 285 samples with non-mixed-field reaction yielded 1,710 antigen results with 8 discrepancies (0.47%) six of which in DAT-positive subjects: three false-positive (Fya) for MDmulticard, and two false-positive (Fya) plus three false-negative (Fyb) for the reference methods (MDmulticard PPA for donors/patients/newborns: 99.82%; negative percent agreement: 100%; sensitivity: 100%; specificity: 99.39%, positive predictive value: 99.75%; negative predictive value: 100%). The MDmulticard detected mixed-field in 15 antigen reactions from 13 transfused patients, undetected by the comparative method, with the opposite result in 8 antigens (5 patients).
CONCLUSION: The MDmulticard Basic Extended Phenotype met the criteria prescribed for the testing of donor, patient, DAT-positive, and newborn samples in transfusion laboratory routine.

Entities:  

Keywords:  Duffy antigen; Kidd antigen; Lateral flow technology; MDmulticard; Ss antigens

Year:  2018        PMID: 30498412      PMCID: PMC6257094          DOI: 10.1159/000486606

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  18 in total

1.  Rare blood. An ISBT Working Party report on rare blood donors. International Society of Blood Transfusion.

Authors:  D Anstee; C Levene; D Mallory; M Overbeeke; J Poole; M Reid; E Smart; Y Tani; S Wendel; G Woodfield
Journal:  Vox Sang       Date:  1999       Impact factor: 2.144

2.  Differentiation of autologous ABO, RHD, RHCE, KEL, JK, and FY blood group genotypes by analysis of peripheral blood samples of patients who have recently received multiple transfusions.

Authors:  P Rozman; T Dovc; C Gassner
Journal:  Transfusion       Date:  2000-08       Impact factor: 3.157

3.  Alloimmunization and clinical profile of sickle cell disease patients from Salvador-Brazil.

Authors:  Angela Maria Dias Zanette; Marilda de Souza Gonçalves; Laíse Vilasboas Schettini; Lais Magalhães Aguiar; Regina Célia Santos Bahia; Luciana Araujo Vasconcelos Nogueira; Cláudio José de Freitas Brandão; Ana Claudia Neves de Azevedo; Luciana Ramos de Aragao; Sérgio Marcos Arruda
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

4.  Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies.

Authors:  V Weisbach; T Kohnhäuser; R Zimmermann; J Ringwald; E Strasser; J Zingsem; R Eckstein
Journal:  Transfus Med       Date:  2006-08       Impact factor: 2.019

5.  Evaluation of a lateral flow-based technology card for blood typing using a simplified protocol in a model of extreme blood sampling conditions.

Authors:  Benoît Clavier; Thomas Pouget; Anne Sailliol
Journal:  Transfusion       Date:  2017-11-29       Impact factor: 3.157

6.  [Suitability of monoclonal test sera for determination of blood group markers in positive direct Coombs test].

Authors:  E Strobel; J Wüllenweber
Journal:  Infusionsther Transfusionsmed       Date:  1995-04

7.  Application of a Multivariant, Caucasian-Specific, Genotyped Donor Panel for Performance Validation of MDmulticard®, ID-System®, and Scangel® RhD/ABO Serotyping.

Authors:  Christoph Gassner; Esther Rainer; Elfriede Pircher; Lydia Markut; Günther F Körmöczi; Christof Jungbauer; Dietmar Wessin; Roswitha Klinghofer; Harald Schennach; Peter Schwind; Diether Schönitzer
Journal:  Transfus Med Hemother       Date:  2009-05-18       Impact factor: 3.747

8.  [Frequency of red blood cell alloimmunization in polytransfused patients at the university teaching hospital of Point G, Bamako, Mali].

Authors:  M Baby; S Fongoro; M Cissé; Y Gakou; M Bathily; A K Dembélé; M K Maïga; A Tounkara; D A Diallo
Journal:  Transfus Clin Biol       Date:  2010-10-18       Impact factor: 1.406

9.  Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.

Authors:  Oswaldo Castro; S Gerald Sandler; Patricia Houston-Yu; Sohail Rana
Journal:  Transfusion       Date:  2002-06       Impact factor: 3.157

10.  Partial matching of blood group antigens to reduce alloimmunization in Western India.

Authors:  Harita Gogri; Swati Kulkarni; K Vasantha; Seema Jadhav; Kanjaksha Ghosh; Ajit Gorakshakar
Journal:  Transfus Apher Sci       Date:  2016-03-10       Impact factor: 1.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.